🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

57 results for “Nektar Therapeutics UK Limited” Clear

  1. LY3471851

    Nektar Therapeutics UK Limited

    Dermatitis, Atopic

    phase 1 small molecule completed

    1 trial

  2. LY3471851

    Nektar Therapeutics UK Limited

    Healthy

    phase 1 small molecule completed

    4 trials

  3. NKTR-102

    Nektar Therapeutics UK Limited

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  4. NKTR-181

    Nektar Therapeutics UK Limited

    Moderate to Severe Chronic Pain

    phase 1 small molecule terminated

    1 trial

  5. NKTR-214

    Nektar Therapeutics UK Limited

    Advanced Cancer

    phase 1 mab completed

    1 trial

  6. NKTR-255

    Nektar Therapeutics UK Limited

    Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  7. Nivolumab

    Nektar Therapeutics UK Limited

    Renal Cell Carcinoma

    phase 1 mab completed

    1 trial

  8. Placebo

    Nektar Therapeutics UK Limited

    Psoriasis

    phase 1 small molecule completed

    1 trial

  9. TAK-659

    Nektar Therapeutics UK Limited

    Lymphoma, Non-Hodgkin

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources